Loading patent…
AssigneesSph Sine Pharmaceutical Laboratories Co., Ltd, Shanghai Institute of Endocrine and Metabolic Diseases
InventorsBin WEN, Guang NING, Xin MA, Weiqing WANG, Hongjing YU, Jie HONG, Ningyun SUN, Jiqiu WANG, Peijun YIN, Ruixin LIU, Yuan GAO, Shasha WANG
Estimating the term…
Provided are an Akkermansia muciniphila strain and use thereof in preventing and treating metabolic diseases. This strain is named Akkermansia muciniphila SSYD-3 and the accession number thereof is CGMCC No. 14764. This strain is more ideal than the existing Ackermannia strain ATCC BAA835 in respect of fermentation performance, storage stability, acid and bile resistance, and the effect on treating metabolic diseases.
A preparation comprising a strain for preventing and treating metabolic diseases, wherein the strain is Akkermansia muciniphila strain, which is named Akkermansia muciniphila SSYD-3 with accession number of CGMCC No. 14764 for the deposit.
A method for preventing and treating metabolic diseases in a subject in need thereof, comprising:
A strain composition comprising a strain and a mixture, wherein the strain is Akkermansia muciniphila strain, which is named Akkermansia muciniphila SSYD-3 with accession number of CGMCC No. 14764 for the deposit.
Dependencies are inferred from the claim text.